AI maps heart's faulty signals to boost AFib treatment

NCT ID NCT06935591

Recruiting now Disease control Sponsor: Vektor Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding an AI-powered heart mapping system (vMap) to the standard ablation procedure helps treat atrial fibrillation (AF) better than ablation alone. About 423 adults with persistent or recurrent AF will be randomly assigned to either standard treatment or standard treatment plus vMap guidance. The main goal is to see if more people stay free of AF for 12 months after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

Contacts and locations

Locations

Arrhythmia Research Group - St. Bernards
RECRUITING

Jonesboro, Arkansas, 72401, United States
Baptist Health Jacksonville
RECRUITING

Jacksonville, Florida, 32207, United States
Baptist Health Lexignton
RECRUITING

Lexington, Kentucky, 40503, United States
BayCare Health System
RECRUITING

Clearwater, Florida, 33759, United States
German Heart Center
RECRUITING

Munich, 80636, Germany
Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States
OhioHealth
RECRUITING

Columbus, Ohio, 43202, United States
Penn Presbyterian
RECRUITING

Philadelphia, Pennsylvania, 19104-4238, United States
Piedmont Heart Institute
RECRUITING

Atlanta, Georgia, 30309, United States
Piedmont Heart of Athens
NOT_YET_RECRUITING

Athens, Georgia, 30606, United States
USF Health
RECRUITING

Tampa, Florida, 33606, United States
University of Toledo Medical Center
NOT_YET_RECRUITING

Toledo, Ohio, 43614, United States
Westchester Medical Center
RECRUITING

Valhalla, New York, 10595, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.